Australia’s biotechnology industry, renowned for its top-notch facilities, researchers, and regulations, is poised to make substantial strides in the development and production of biologics. Increasing domestic manufacturing will help the sector grow even more. Australia’s premier conference, the 3rd ANZ Biologics

Festival 2025, brings together pioneers and executives in the disciplines of biologics, biosimilars, vaccines, cell and gene therapy, and emerging treatments. The program will highlight Australia’s clinical trials and investment prospects, as well as innovations from ideation to commercialization. It offers an excellent venue for networking with every member of the biopharmaceutical industry.